My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 517

    1.

    Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells.

    Li J, Orr B, White K, Belogortseva N, Niles R, Boskovic G, Nguyen H, Dykes A, Park M.

    Mol Cancer. 2009 Feb 12;8:7.PMID: 19216755 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells.

    Li J, Belogortseva N, Porter D, Park M.

    Cell Cycle. 2008 Sep 15;7(18):2886-93. Epub 2008 Sep 26.PMID: 18787405 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells.

    Leelawat K, Ohuchida K, Mizumoto K, Mahidol C, Tanaka M.

    Cancer Lett. 2005 Jun 28;224(2):303-10. Epub 2004 Dec 8.PMID: 15914280 [PubMed - indexed for MEDLINE]Related articles

    4.

    Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model.

    El-Metwally TH, Hussein MR, Abd-El-Ghaffar SKh, Abo-El-Naga MM, Ulrich AB, Pour PM.

    J Clin Pathol. 2006 Jun;59(6):603-10. Epub 2006 Feb 10.PMID: 16473924 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells.

    Guo J, Xiao B, Lou Y, Yan C, Zhan L, Wang D, Zhao W.

    J Gastroenterol Hepatol. 2006 Feb;21(2):443-8.PMID: 16509872 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines.

    Mogaki M, Hirota M, Chaney WG, Pour PM.

    Carcinogenesis. 1993 Dec;14(12):2589-94.PMID: 8269631 [PubMed - indexed for MEDLINE]Related articles

    7.

    Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.

    Park EY, Dillard A, Williams EA, Wilder ET, Pepper MR, Lane MA.

    Cancer Res. 2005 Nov 1;65(21):9923-33.PMID: 16267017 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.

    Shi Y, Sahu RP, Srivastava SK.

    BMC Cancer. 2008 Oct 10;8:294.PMID: 18847491 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in Hela cells.

    Mao WG, Liu ZL, Chen R, Li AP, Zhou JW.

    Clin Exp Pharmacol Physiol. 2006 Sep;33(9):816-24.PMID: 16922813 [PubMed - indexed for MEDLINE]Related articles

    10.

    S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines.

    Radu M, Soprano DR, Soprano KJ.

    J Cell Physiol. 2008 Nov;217(2):558-68.PMID: 18615582 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.

    Rahim R, Strobl JS.

    Anticancer Drugs. 2009 Sep;20(8):736-45.PMID: 19584707 [PubMed - indexed for MEDLINE]Related articles

    12.

    All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines.

    Bold RJ, Ishizuka J, Townsend CM Jr, Thompson JC.

    Pancreas. 1996 Mar;12(2):189-95.PMID: 8720668 [PubMed - indexed for MEDLINE]Related articles

    13.

    Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.

    Zhou R, Shanas R, Nelson MA, Bhattacharyya A, Shi J.

    Int J Cancer. 2010 Jan 15;126(2):395-404.PMID: 19609950 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice.

    Avila GE, Zheng X, Cui XX, Ryan AD, Hansson A, Suh J, Rabson AB, Chang RL, Shih WJ, Lin Y, Crowell P, Lu YP, Lou YR, Conney AH.

    J Pharmacol Exp Ther. 2005 Oct;315(1):170-87. Epub 2005 Jun 23.PMID: 15976015 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes.

    Dong M, Dong Q, Zhang H, Zhou J, Tian Y, Dong Y.

    J Surg Oncol. 2007 Mar 15;95(4):332-6.PMID: 17230496 [PubMed - indexed for MEDLINE]Related articles

    16.

    On the role of transforming growth factor-beta in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells.

    Singh B, Murphy RF, Ding XZ, Roginsky AB, Bell RH Jr, Adrian TE.

    Mol Cancer. 2007 Dec 24;6:82.PMID: 18157915 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Effects of interferon-gamma combined with all-trans retinoic acid on proliferation and differentiation of leukemia cell lines NB4 and MR2]

    He PC, Zhang M, Wu D, Xu H, Cai RB, Liu YL.

    Ai Zheng. 2006 Dec;25(12):1477-82. Chinese. PMID: 17166370 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of all-trans retinoic acid on tissue dynamics of choriocarcinoma cell lines: an organotypic model.

    Chiu PM, Feng HC, Benbrook DM, Ngan HY, Khoo US, Xue WC, Tsao SW, Chan KW, Cheung AN.

    J Clin Pathol. 2006 Aug;59(8):845-50. Epub 2006 Feb 6.PMID: 16461808 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis.

    Donadelli M, Dalla Pozza E, Scupoli MT, Costanzo C, Scarpa A, Palmieri M.

    Biochim Biophys Acta. 2009 Feb;1793(2):273-80. Epub 2008 Oct 7.PMID: 18951928 [PubMed - indexed for MEDLINE]Related articles

    20.

    Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.

    Yan W, Liu G, Scoumanne A, Chen X.

    Cancer Res. 2008 Aug 15;68(16):6789-96.PMID: 18701504 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk